购物车
- 全部删除
- 您的购物车当前为空
INX-315, an orally active and selective CDK2 inhibitor, induces cell cycle arrest in the G1 phase, reduces CDK2 substrate phosphorylation, and inhibits tumor growth dose-dependently in xenograft mouse models. INX-315 may be used in cancer research [1].
INX-315, an orally active and selective CDK2 inhibitor, induces cell cycle arrest in the G1 phase, reduces CDK2 substrate phosphorylation, and inhibits tumor growth dose-dependently in xenograft mouse models. INX-315 may be used in cancer research [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | INX-315, an orally active and selective CDK2 inhibitor, induces cell cycle arrest in the G1 phase, reduces CDK2 substrate phosphorylation, and inhibits tumor growth dose-dependently in xenograft mouse models. INX-315 may be used in cancer research [1]. |
分子量 | 427.48 |
分子式 | C19H21N7O3S |
CAS No. | 2745060-92-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.